Every organization desires to close the year with significant profits. This is precisely the situation at Altium Capital Management, a New-York based investment management company. Most recently, the firm went public with a growth report showing the fund’s impressive numbers from last year’s activities. For instance, one of its capital products, Altium Growth Fund presented great returns of 7.37% for the period between June and October this year. If you do your math right, that is precisely just five months.
Altium Growth Fund specializes in products linked to equity, mid-cap equities, as well as small-cap equities. The fund also makes significant investments in the U.S and global sub-sectors of healthcare including biotech services, medical technology and devices, life science tools, as well as primary and specialty pharmacy. The Delaware limited partnership has dramatically contributed to the dramatic success at Altium Capital Management, LP.
The Innovative Model of Healthcare Investment
Notably, Altium Capital Management, LP is an investment firm exclusively operating in the healthcare industry. It primarily deals with investment opportunities that arise within the healthcare operations. The firm focuses on generating returns in a wide range of equity-based products within the healthcare sector. It aims at carrying out extensive research for purposes of facilitating positively expected value trades through the analysis of asymmetric opportunities from risk rewards.
Altium Capital Management heavily relies on an investment approach that focuses on a thorough research process on maximizing capital on pricing inefficiencies found within mid and small-cap sectors of the industry. In particular, equities and other investment options with dynamic bonds serve as the financial instruments for the fund. The application of swaps and other derivatives is usually on a selective basis. The approach aims at identifying ideas that are fundamental in enhancing the growth of the global healthcare industry. Nonetheless, the primary goal is on designing an attractive risk-adjusted returns model that is at a higher level compared to the traditional forms of equity investments.
Over the years, Altium Capital Management, LP has established successful investments with a different organization in the healthcare industry. Some of its recent investments in the sector include those with firms working on designing innovative oral treatment alternatives to help diabetes patients and others on concerns revolving around the development of cardiovascular drugs. Altium Capital is also teaming up with a major that focuses on developing antibiotics for infectious diseases and oral mucositis treatment.
The Company thrives under a team of seasoned top-notch investment professionals with vast experience and expertise in the healthcare industry and matters involving hedge funds. The professionals also boast of proven track records of successful investments within the healthcare industry. With their help, Altium Capital is in the best position to gain a competitive advantage against other firms in this business.
About Jacob Gottlieb
Serving as the Chief Executive Officer and Managing Partner of Altium Capital Management, Jacob Gottlieb has seen the firm through significant growth and development. He is a successful entrepreneur in the field of finance, often praised for his expertise in healthcare investments. Gottlieb mostly deals with enterprises that provide advances on essential health and medical treatment.
Before founding Altium Capital in 2007, Gottlieb worked in many other investment firms where he held top prestigious positions. During his reign in some of these companies like Visium, an asset management, his efforts were notable through the various milestones he helped them achieve. Following his vast experience and exceptional skills in alternative investments, asset management, and hedge funds, Gottlieb has significantly enhanced the tremendous success witnessed in many companies.
Jacob bases his career on solid educational background. He owns a Master’s Degree, Doctorate, and Medical Internship from New York University’s medical school. He also graduated from Brown University with AB, Economics specializing in activities and societies.